Aortic Stent Grafts Market to Surpass 3.01 Billion by 2030 Drives Due to Medical Advancements
SkyQuest projects that the aortic stent grafts market will attain a USD 3.01 billion value by 2030, with a CAGR of 4.5% over the forecast period (2023-2030). The aortic stent grafts market is driven by continuous advancements in medical technology, enabling minimally invasive procedures for aortic aneurysm treatment. These stent grafts offer reduced surgical risks and faster patient recovery, fostering market growth.
Westford USA , Oct. 19, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, the rising geriatric population prone to aortic disorders fuels demand for stent grafts. The aortic stent grafts market experiences a natural boost in demand, driving market expansion as age-related vascular complications increase.
Browse In-Depth TOC on the "Aortic Stent Grafts Market"
Pages - 157
Tables - 61
Figures – 75
Get sample copy of this report:
https://www.skyquestt.com/sample-request/aortic-stent-grafts-market
Growing awareness about aortic diseases and the availability of effective treatments through government initiatives and healthcare campaigns drive the adoption of aortic stent grafts. Increased screening efforts result in early diagnosis and treatment, stimulating aortic stent grafts market growth in the long run.
Prominent Players in the Aortic Stent Grafts Market
Medtronic Plc
Cook Medical Inc.
Endologix Inc.
W.L. Gore & Associates Inc.
Terumo Corporation
Lombard Medical Technologies
MicroPort Scientific Corporation
Merit Medical Systems Inc.
JOTEC GmbH
CryoLife Inc.
Lifetech Scientific (Shenzhen) Co. Ltd.
Becton, Dickinson and Company
Endospan Ltd.
Cardinal Health Inc.
MicroVention Inc.
Aptus Endosystems Inc.
Altura Medical Inc.
Penumbra Inc.
Biomerics LLC
Lombardi SA
Browse summary of the report and Complete Table of Contents (ToC):
https://www.skyquestt.com/report/aortic-stent-grafts-market
Thoracic Aortic Stent Graft Segment is Expected to Grow the Market Due to Advancements in Minimally Invasive Treatments
Thoracic aortic stent graft segment is emerging as the fastest growing aortic stent grafts market due to remarkable advancements in minimally invasive treatments. Rising cases of thoracic aortic diseases coupled with the effectiveness of these grafts drive their adoption. This segment's growth is further propelled by increased awareness, improved patient outcomes, and ongoing research enhancing the technology.
North America stands out as the fastest-growing region in the aortic stent grafts market due to its advanced healthcare infrastructure and high prevalence of cardiovascular diseases. Robust research and development efforts and favorable reimbursement policies drive innovation and adoption. Increasing awareness about minimally invasive treatments also contributes to the region's accelerated growth in aortic stent graft procedures.
Abdominal Aortic Stent Graft Segment is Expected to Dominate the Market Due to Prevalence Among Abdominal Aortic Aneurysms
Abdominal aortic stent graft segment asserts dominance in the aortic stent grafts market due to its prevalence among abdominal aortic aneurysms. The leading position is attributed to a heightened emphasis on early diagnosis and preventive interventions. This segment benefits from extensive adoption in hospitals and ambulatory surgical centers, supported by a growing elderly population and heightened healthcare awareness.
Asia Pacific emerges as a dominant force in the aortic stent grafts market due to its expanding patient pool, rapid urbanization, and improved healthcare accessibility. Rising cases of aortic diseases and a growing aging population fuel demand. Collaborations between global manufacturers and local healthcare providers further amplify the region's prominence, driving steady growth in aortic stent graft adoption.
A comprehensive analysis of the major players in the aortic stent grafts market has been recently conducted in a report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavors to develop innovative solutions to cater to the growing demand.
Key Developments in the Aortic Stent Grafts Market
In 2022, TERUMO Aortic announced the approval of the RelayPro thoracic stent graft system by Japan's PMDA for treating individuals with thoracic aortic aneurysms (TAA) in Japan. RelayPro, characterized by its reduced profile, represents a next-generation solution for patients with narrower access points for thoracic aneurysms.
In 2022, Endologix LLC, a trailblazer in vascular disease treatment, revealed the introduction of the ALTO Abdominal Stent Graft in Canada and Argentina. This move marks an expansion of the company's endovascular aneurysm repair (EVAR) product range, reinforcing its commitment to innovative solutions in vascular healthcare.
Speak to Analyst for your custom requirements:
https://www.skyquestt.com/speak-with-analyst/aortic-stent-grafts-market
Key Questions Answered in Aortic Stent Grafts Market Report
What specific growth drivers are projected to impact the market during the forecast period?
List the top companies in the market and explain how they have achieved their positions of influence.
In what ways do regional trends and patterns differ within the global market, and how these differences shape the market's future growth?
Related Reports in SkyQuest’s Library:
Global Laboratory Vacuum Pumps Market
Global Depyrogenated Sterile Empty Vials Market
Global Vaccine Delivery Devices Market
Global Compression Stockings Market
About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
Address:
1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com
